Movesan (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Movesan, is a corticosteroid presented as a topical formulation for cutaneous use. It is employed to reduce inflammation and relieve symptoms in various dermatologic conditions affecting adults and children. The medication works by modulating immune responses in the skin, providing anti‑inflammatory and antipruritic effects.

GNH USA supplies Movesan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality and regulatory compliance.

Mometasone Furoate is a potent topical corticosteroid used to manage inflammatory skin disorders.

- Psoriasis: reduces plaque thickness, scaling and erythema. - Atopic dermatitis (eczema): alleviates itching, redness and inflammation. - Seborrheic dermatitis: controls flaking and irritation on scalp and face. - Contact dermatitis: diminishes allergic skin reactions and swelling. - Lichen planus: lessens lesions and associated discomfort.

Topical application of mometasone furoate may cause local skin reactions, although many patients tolerate it well.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus or mild itching. - Dryness or peeling of the skin. - Folliculitis or acne‑like eruptions. - Erythema or mild redness.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Development of striae (stretch marks). - Hypopigmentation or depigmentation of treated areas. - Secondary bacterial, fungal or viral infections. - Systemic adrenal suppression when large areas are treated. - Allergic contact dermatitis or severe hypersensitivity reactions.

Before using Movesan, consider the following safety measures.

- Assess severity: limit use to mild‑moderate conditions unless directed by a specialist. - Duration: avoid continuous application beyond the prescribed period to reduce risk of skin atrophy. - Occlusion: do not cover treated areas with airtight dressings unless instructed. - Infected skin: refrain from use on bacterial, viral or fungal infections without prior treatment. - Pediatric use: avoid in children under two years of age unless specifically indicated. - Store at room temperature: keep in the original container, protect from moisture and light.

Topical mometasone furoate may interact with other agents applied to the skin or systemic medications.

Major Interactions (Avoid):\n- Systemic corticosteroids: concurrent high‑dose systemic steroids increase risk of systemic glucocorticoid effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic absorption of mometasone. - Antifungal agents applied to the same area: can enhance local irritation.

Moderate Interactions (Monitor Closely): - Other topical anti‑inflammatories (e.g., NSAID gels): monitor for additive skin irritation. - Photosensitizing drugs (e.g., tetracyclines): increase risk of phototoxic reactions. - Live vaccines: avoid administration if significant systemic absorption is suspected.